中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2014年
8期
16-17
,共2页
非那雄胺%坦索罗辛%前列腺增生症(BPH)
非那雄胺%坦索囉辛%前列腺增生癥(BPH)
비나웅알%탄색라신%전렬선증생증(BPH)
Finasteride%Tansuoluoxin%Benign prostatic hyperplasia (BPH)
目的：观察非那雄胺联合坦索罗辛治疗前列腺增生症的临床疗效。方法：将80例患者随机分成两组,治疗组患者采用非那雄胺联合坦索罗辛治疗,对照组患者单用非那雄胺治疗。两组患者均治疗1年,分别在3个月、6个月与1年,分别记录IPSS评分,MFR前列腺体积和残余尿量等指标,比较两组临床疗效。结果：治疗组治疗后IPSS评分明显下降,最大尿流率升高,残余尿量减少,前列腺体积减小,以上指标均明显优于对照组；治疗组总有效率92.5%,高于对照组的72.5%,两者比较有统计学意义(P<0.05)。结论：非那雄胺联合坦索罗辛治疗前列腺增生症( BPH),可减轻前列腺症状,改善最大尿流率,减少尿潴留及前列腺源性血尿及手术干预的发生率。
目的：觀察非那雄胺聯閤坦索囉辛治療前列腺增生癥的臨床療效。方法：將80例患者隨機分成兩組,治療組患者採用非那雄胺聯閤坦索囉辛治療,對照組患者單用非那雄胺治療。兩組患者均治療1年,分彆在3箇月、6箇月與1年,分彆記錄IPSS評分,MFR前列腺體積和殘餘尿量等指標,比較兩組臨床療效。結果：治療組治療後IPSS評分明顯下降,最大尿流率升高,殘餘尿量減少,前列腺體積減小,以上指標均明顯優于對照組；治療組總有效率92.5%,高于對照組的72.5%,兩者比較有統計學意義(P<0.05)。結論：非那雄胺聯閤坦索囉辛治療前列腺增生癥( BPH),可減輕前列腺癥狀,改善最大尿流率,減少尿潴留及前列腺源性血尿及手術榦預的髮生率。
목적：관찰비나웅알연합탄색라신치료전렬선증생증적림상료효。방법：장80례환자수궤분성량조,치료조환자채용비나웅알연합탄색라신치료,대조조환자단용비나웅알치료。량조환자균치료1년,분별재3개월、6개월여1년,분별기록IPSS평분,MFR전렬선체적화잔여뇨량등지표,비교량조림상료효。결과：치료조치료후IPSS평분명현하강,최대뇨류솔승고,잔여뇨량감소,전렬선체적감소,이상지표균명현우우대조조；치료조총유효솔92.5%,고우대조조적72.5%,량자비교유통계학의의(P<0.05)。결론：비나웅알연합탄색라신치료전렬선증생증( BPH),가감경전렬선증상,개선최대뇨류솔,감소뇨저류급전렬선원성혈뇨급수술간예적발생솔。
Objective:To observe clinical effects of finasteride combined with tansuoluoxin for benign prostatic hyperplasia (BPH). Methods:80 patients were randomly divided into treatment group (treated with finasteride and tansuoluoxin) and control group (only treated with finasteride). The two groups were treated for 1 year. The clinical efficacy was compared between the two groups 3 months, 6 months, and 1 year after the treatment. Results:The total effective rate of treatment group was significantly higher than that of control group. Conclusions:Finasteride combined with tansuoluoxin for benign prostatic hyperplasia ( BPH) can alleviate the clinical symptoms, improve the maximal urinary flow rate, and reduce the incidence of uroschesis and hematuria.
